Ibhar

What Ibhar does

Ibhar Technologies Pvt Ltd is a Chennai-based healthcare technology company that builds the Ibhar Infection Intelligence Platform for hospitals, clinicians, and public-health programs focused on antimicrobial resistance (AMR) and healthcare-associated infection (HAI) prevention. The company sells primarily to Indian hospitals and health systems, with engagement history spanning teaching institutions, public-sector facilities, private hospital networks, and mission-driven healthcare organizations, and has extended partnerships into Africa via ICAN. Its core proposition is moving infection prevention from periodic manual reporting to continuous, data-driven intelligence across the surveillance-to-stewardship workflow.

The platform is structured as three integrated modules — Infection Prevention Intelligence (digital surveillance, HAI monitoring, environmental surveillance, dashboards), Clinical Microbiology Intelligence (structured culture and susceptibility reporting, organism distribution and resistance trend analysis, automated hospital- and unit-specific antibiograms, MIC guidance), and Antimicrobial Stewardship Intelligence (antibiotic utilization analytics, prescription monitoring, therapy optimization, policy compliance). Underlying capabilities include AI-driven microbiology reporting and anomaly detection for outbreak signals, with a documented dataset of approximately 500,000 positive culture records and evidence from 150+ participating hospitals. The company has built a parallel certification offering through the ACHSI–Ibhar Continuous Infection Prevention Certification Program, combining international accreditation standards with its surveillance technology.

The business model is enterprise B2B SaaS sold to hospitals and health systems on a subscription basis, with quote-based pricing and no publicly disclosed rates. Go-to-market relies heavily on institutional partnerships — CAHO (over a decade), AHPI, ACHSI, HIQT, 3M (LEAP), Pfizer (AMR Initiative, ~25 hospitals), JIPMER as WHO Technical Partner (100+ hospital study), Trinity Challenge with Clinton Foundation, WHO, and VIT — rather than high-velocity field sales. The company is privately held, founder-controlled, headquartered at 7th Floor, Sapna Trade Center, Chennai, and has been recognized internationally including a UNAIDS-HIEx & PandemicTech Globalization Award (2020), Ayushman Bharat Startup Grand Challenge Finalist (2021), Trinity Challenge Finalist (2023), and UN AIDS HieX Innovation Recognition (2023).

Name

Ibhar

Legal name

Ibhar Technologies Pvt Ltd

Website

https://ibhar.com

Company type

Private

Operating status

Operating

Headcount range

11–50 employees

Short description

Ibhar Technologies builds the Infection Intelligence Platform, an enterprise SaaS solution connecting infection surveillance, microbiology reporting, and antimicrobial stewardship for hospitals, clinicians, and public-health programs combating antimicrobial resistance in India and selectively internationally.

Ownership category

akta.pro rank

Product category

Hospital Infection Prevention and Antimicrobial Stewardship Software

NAICS

Software Publishers (513210), Software Publishers (5132), Medical and Diagnostic Laboratories (62151)

SIC

In Vitro & In Vivo Diagnostic Substances (2835)

akta.pro primary industry

Digital & AI-Enabled Diagnostics (algorithmic interpretation, decision support tied to assays) (HLAAALAO)

akta.pro secondary industry

iBPMS (Intelligent BPM Suites) & Process Automation Suites (HDAEAHAG)

Keywords

• Infection surveillance software
• Antimicrobial stewardship
• Clinical microbiology intelligence
• Healthcare-associated infection monitoring
• Hospital infection prevention

Headquarters

HQ city

Chennai

HQ country

India

HQ region

Asia

Offices1 record

Markets served

GTM type

B2B

Offering type

Software

Cost components

Personnel, Technology or R&D, Marketing or Sales, Operations

Revenue model

1. Infection Intelligence Platform Subscription: SaaS platform subscription for hospitals to access infection surveillance, microbiology intelligence, and antimicrobial stewardship tools.

Go-to-market motion1 record

Distribution channels2 records

Marketing channels4 records

Core offering

Ibhar develops and sells the Ibhar Infection Intelligence Platform, a B2B SaaS solution for hospitals that unifies infection surveillance, clinical microbiology reporting, and antimicrobial stewardship into a single digital environment. The platform ingests hospital data sources to produce AI-driven antibiograms, antibiotic utilization analytics, healthcare-associated infection monitoring, and real-time infection trend dashboards, enabling earlier outbreak detection and evidence-based antibiotic therapy decisions. Ibhar also co-delivers the ACHSI–Ibhar Continuous Infection Prevention Certification Program, bundling internationally accredited certification with its digital surveillance technology.

Product overview

Ibhar offers a unified Infection Intelligence Platform that integrates three core modules: Infection Prevention Intelligence, Clinical Microbiology Intelligence, and Antimicrobial Stewardship Intelligence. The platform digitizes infection surveillance workflows, transforms culture and susceptibility data into actionable clinical intelligence, and provides consolidated dashboards for hospital leadership. Supporting over 800 hospitals, the platform enables continuous infection intelligence rather than periodic reporting, supporting evidence-based antibiotic therapy decisions and proactive infection prevention.

Differentiator

Problem solved

Functional benefit

Products and services

• Ibhar Infection Intelligence Platform A unified enterprise SaaS platform for hospitals that connects infection surveillance, microbiology intelligence, and antimicrobial stewardship workflows into a single digital environment, transforming fragmented infection data into continuous actionable clinical intelligence for infection control teams, microbiologists, clinicians, and hospital leadership.
• ACHSI–Ibhar Continuous Infection Prevention Certification Program A certification program for hospitals that combines Australian Council on Healthcare Standards International (ACHSI) accreditation expertise with Ibhar's digital surveillance technology, enabling hospitals to demonstrate measurable, transparent, and continuously improving infection prevention practices.

Quantifiable outcome

• Hospitals implementing the Ibhar platform achieve earlier detection of infection risks and outbreak signals, supporting faster intervention and improved clinical outcomes.
• +3 more outcomes

Named customers6 records

Segments6 records

Ideal customer profiles2 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability3 records

Feature9 records

Partnerships

Twelve partnerships are on record, tiered core, supporting and flagship.

• CAHO (Consortium of Accredited Healthcare Organizations)coreStrategic or Co-development PartnerOver a decade of collaboration supporting quality and safety practices across hospitals. CAHO initiatives include Fire Safety preparedness, CAHO Learning Platform (CLAPP), CONVERT confidential incident reporting system, and license management tools. Ibhar's digital platforms enable thousands of healthcare professionals to participate in structured learning, safety reporting, and compliance management.
• AHPI (Association of Healthcare Providers India)coreStrategic or Co-development PartnerPartnership for healthcare capacity building across India. AHPI represents a large network of hospitals working to advance healthcare quality, policy dialogue, and capacity building.
• PfizercoreGTM or Marketing PartnerAMR Initiative partnership supporting approximately 25 major hospitals in strengthening antimicrobial stewardship programs and monitoring antibiotic use.
• Healthcare Institute of Quality & Technology (HIQT)supportingStrategic or Co-development PartnerEquips ICU teams with infection prevention capabilities through a training curriculum aligned with WHO-adopted frameworks.
• 3MsupportingGTM or Marketing PartnerLEAP partnership helping hospitals prepare for accreditation and strengthen quality management and patient safety systems.
• ACHSI (Australian Council on Healthcare Standards International)coreStrategic or Co-development PartnerContinuous Infection Prevention Certification Program combining internationally recognized accreditation expertise with Ibhar's advanced digital surveillance technology for measurable, transparent, and continuously improving infection prevention practices.
• JIPMER (Jawaharlal Institute of Postgraduate Medical Education and Research)coreStrategic or Co-development PartnerWHO Technical Partner leading the largest antibiogram study with over 100 hospitals using Ibhar's AMS solution. Study focuses on AMR resistance pattern analysis across multi-hospital settings.
• Trinity Challenge (with Clinton Foundation)flagshipStrategic or Co-development PartnerTrinity Challenge Finalist recognition for contributions to combating antimicrobial resistance. The Clinton Foundation collaboration focuses on global health innovation.
• WHO (World Health Organization)flagshipStrategic or Co-development PartnerWHO-supported AMR studies and technical partnership for antimicrobial resistance surveillance and infection prevention programs.
• ICAN AfricasupportingStrategic or Co-development PartnerICAN Africa initiatives contributing to regional antimicrobial resistance response and infection prevention efforts.
• VIT (Vellore Institute of Technology)supportingStrategic or Co-development PartnerCollaboration with VIT to enhance patient safety and clinical outcomes through technology and research partnerships.
• Indian Chamber of Commerce and Industry, CoimbatoresupportingStrategic or Co-development PartnerPilot project collaboration to control infections at hospitals in the Coimbatore region.

Scale indicators6 records

Recent moves6 records

Expansion highlights6 records

Broad incumbents

• Oracle Health (formerly Cerner): Oracle Health's EHR includes infection control, antimicrobial stewardship, and microbiology integration modules that overlap with Ibhar's three-module platform, and benefits from deep integration advantages with hospital IT systems.
• Wolters Kluwer (Sentri7 / UpToDate): Wolters Kluwer's Sentri7 and clinical decision support suites provide antimicrobial stewardship and infection-related guidance to hospitals at scale, competing with Ibhar's stewardship module from an established, well-capitalized incumbent position.
• bioMérieux: bioMérieux combines microbiology diagnostics with the BioBall and lab informatics offerings, addressing the same microbiology-to-stewardship workflow that Ibhar's Clinical Microbiology Intelligence module targets, but as part of a much larger diagnostics franchise.
• Epic Systems: Epic's EHR suite includes infection surveillance, antimicrobial stewardship workflows, and microbiology reporting — competing with Ibhar as a bundled offering for large hospital networks, particularly in academic medical centers.
• Becton Dickinson (BD): BD offers infection prevention products and surveillance/diagnostic informatics for hospitals, and competes broadly with Ibhar's antimicrobial stewardship and HAI monitoring modules as part of its broader medtech portfolio.
• Premier Inc. Premier provides healthcare performance improvement and analytics, including services that overlap with Ibhar's hospital leadership dashboards and stewardship performance reporting for US health systems.

Direct peers

• VigiLanz: VigiLanz provides a SaaS infection surveillance and antimicrobial stewardship platform for hospitals, making it the closest direct peer to Ibhar's Infection Intelligence Platform in functionality and customer base.
• RLDatix: RLDatix (formed via the merger of RL Solutions and Datix) offers patient safety, incident reporting, and infection prevention software to hospitals globally, overlapping directly with Ibhar's infection surveillance and governance modules.

Emerging players

• Therapeutic Monitoring Systems (TMS): TMS focuses on antimicrobial stewardship decision support and prospective audit tools for hospitals, representing an emerging niche competitor with partial overlap to Ibhar's stewardship intelligence module.

Others

• APIC (Association for Professionals in Infection Control): While not a vendor, APIC sets infection prevention standards and runs industry programs; Ibhar's positioning through CAHO, AHPI, and ACHSI parallels how APIC drives software purchasing decisions in the US market.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

Compliance4 records

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Ibhar